DEF 14A
DEF 14A
- Company
- REVELATION BIOSCIENCES, INC.
- Filed
- February 17, 2026
- Period of Report
- February 14, 2026
- Accession Number
- 0001193125-26-053984
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →